EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HLA-DR3 ~ DQ2 associates with sensory neuropathy in paraneoplastic neurological syndromes with Hu antibodies

Sergio Muñiz-Castrillo, Macarena Villagrán-García, Vicente Peris Sempere, Antonio Farina, Anne-Laurie Pinto, Géraldine Picard, Véronique Rogemond, Jérôme Honnorat, Emmanuel Mignot

Journal of Neurology · 2024

DOI: 10.1007/s00415-024-12534-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurology, 2024. Verfasst von Sergio Muñiz-Castrillo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Stanford Center for Sleep Sciences and Medicine, Stanford University, 3165 Porter Drive, Palo Alto, CA, 94304, USA. Hauptthemen laut MEDLINE: Paraneoplastic Syndromes, Nervous System, Autoantibodies. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, European Reference Network RITA, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To investigate the association between human leukocyte antigen (HLA) and paraneoplastic neurological syndromes (PNS) with Hu antibodies, and potential specificities according to clinical presentation and cancer status.

Methods

HLA genotypes at four-digit resolution were imputed from available genome-wide association data. Allele carrier frequencies were compared between patients (whole cohort, n = 100, and according to clinical presentation and cancer status) and matched healthy controls ( n = 508) using logistic regression controlled by the three main principal components.

Results

The clinical presentation of 100 anti-Hu patients involved the central nervous system (28, 28%), the peripheral nervous system (36, 36%) or both combined (36, 36%). Cancer diagnosis was certain in 75 (75%). HLA association analyses revealed that anti-Hu PNS patients were more frequently carriers of DQA1*05:01 (39% vs. 19%, OR = 2.8 [1.74–4.49]), DQB1*02:01 (39% vs. 18%, OR = 2.88 [1.79–4.64]) and DRB1*03:01 (41% vs. 19%, OR = 2.92 [1.80–4.73]) than healthy controls. Remarkably, such DR3 ~ DQ2 association was absent in patients with pure central involvement, but more specific to those manifesting with peripheral involvement: DQA1*05:01 (OR = 3.12 [1.48–6.60]), DQB1*02:01 (OR = 3.35 [1.57–7.15]) and DRB1*03:01 (OR = 3.62 [1.64–7.97]); being even stronger in cases with sensory neuropathy, DQA1*05:01 (OR = 4.41 [1.89–10.33]), DQB1*02:01 (OR = 4.85 [2.04–11.53]) and DRB1*03:01 (OR = 5.79 [2.28–14.74]). Similarly, DR3 ~ DQ2 association was only observed in patients with cancer.

Discussion

Patients with anti-Hu PNS show different HLA profiles according to clinical presentation and, probably, cancer status, suggesting pathophysiological differences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Paraneoplastic Syndromes, Nervous SystemAutoantibodiesHumansMaleFemaleMiddle AgedAgedAdultHLA-DR3 AntigenHLA-DQ Antigens

Stichwörter der Autor:innen

HLAHu antibodyParaneoplastic neurological syndromesSmall-cell lung cancer

Substanzen

AutoantibodiesHLA-DQ2 antigenHLA-DR3 AntigenHLA-DQ Antigens

Autor:innen und Institutionen

  • Stanford Center for Sleep Sciences and Medicine, Stanford University, 3165 Porter Drive, Palo Alto, CA, 94304, USA.
  • French Reference Center for Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis, Hospices Civils de Lyon, Lyon, France.
  • MeLiS, UCBL-CNRS UMR 5284, INSERM U1314, Université Claude Bernard Lyon 1, Lyon, France.
  • Stanford Center for Sleep Sciences and Medicine, Stanford University, 3165 Porter Drive, Palo Alto, CA, 94304, USA. mignot@stanford.edu.

Förderung

  • Agence Nationale de la Recherche
  • European Reference Network RITA
  • NIH HHS
  • National Institutes of Health
  • Fundación Alfonso Martín Escudero

Zitieren

APA

Muñiz-Castrillo, S., Villagrán-García, M., Peris Sempere, V., Farina, A., Pinto, A. L., Picard, G., Rogemond, V., Honnorat, J., & Mignot, E. (2024). HLA-DR3 ~ DQ2 associates with sensory neuropathy in paraneoplastic neurological syndromes with Hu antibodies. Journal of Neurology. https://doi.org/10.1007/s00415-024-12534-7

Vancouver

Muñiz-Castrillo S, Villagrán-García M, Peris Sempere V, Farina A, Pinto AL, Picard G, et al. HLA-DR3 ~ DQ2 associates with sensory neuropathy in paraneoplastic neurological syndromes with Hu antibodies. Journal of Neurology. 2024. doi:10.1007/s00415-024-12534-7

BibTeX
@article{MuizCastrillo2024,
  author = {Muñiz-Castrillo, Sergio and Villagrán-García, Macarena and Peris Sempere, Vicente and Farina, Antonio and Pinto, Anne-Laurie and Picard, Géraldine and Rogemond, Véronique and Honnorat, Jérôme and Mignot, Emmanuel},
  title = {HLA-DR3 ~ DQ2 associates with sensory neuropathy in paraneoplastic neurological syndromes with Hu antibodies},
  journal = {Journal of Neurology},
  year = {2024},
  doi = {10.1007/s00415-024-12534-7}
}
Kostenlos starten →